articleTop 10% cited
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Neurology · 2002 · Vol. 58(12) · pp. 1791–1800
Dietmar Rudolf Thal✉(University of Bonn)Udo Rüb(University of Bonn)M Orantes(University of Bonn)Heiko Braak(University of Bonn)
Abstract
Abeta-deposition in the entire brain follows a distinct sequence in which the regions are hierarchically involved. Abeta-deposition, thereby, expands anterogradely into regions that receive neuronal projections from regions already exhibiting Abeta. There are also indications that clinically proven AD cases with full-blown beta-amyloidosis may be preceded in early stages by nondemented cases exhibiting AD-related Abeta pathology.
Alzheimer's disease research and treatmentsAmyloidosis: Diagnosis, Treatment, OutcomesDementia and Cognitive Impairment ResearchBrainstemPathologyNeocortexForebrainNeuroscienceBasal forebrainReticular formationHuman brainCerebellumCholinergic
MeSH terms
AdultAgedAged, 80 and overAlzheimer DiseaseBrainFemaleHumansMaleMiddle AgedModels, NeurologicalAmyloid beta-PeptidesStatistics, Nonparametric
Citations
3,414
FWCI
7.97
field-weighted impact
References
53
Percentile
98%
vs. same field & year
Citations per year
Cited by
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Science Translational Medicine · 2016 · 732 citations
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Journal of Cerebral Blood Flow & Metabolism · 2005 · 716 citations
Alzheimer’s disease: experimental models and reality
Acta Neuropathologica · 2016 · 787 citations
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
Acta Neuropathologica · 2011 · 2,870 citations
The pathological process underlying Alzheimer’s disease in individuals under thirty
Acta Neuropathologica · 2010 · 803 citations
Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Journal of Clinical Investigation · 2012 · 1,804 citations
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Annals of Neurology · 2004 · 4,451 citations
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Neurobiology of Aging · 2003 · 961 citations
References
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Proceedings of the National Academy of Sciences · 1985 · 4,412 citations
Neuropathological stageing of Alzheimer-related changes
Acta Neuropathologica · 1991 · 16,076 citations
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
Neurobiology of Aging · 1991 · 826 citations
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
Neurobiology of Aging · 1997 · 429 citations
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
Journal of Histochemistry & Cytochemistry · 1981 · 14,242 citations
A New Clinical Scale for the Staging of Dementia
The British Journal of Psychiatry · 1982 · 7,000 citations
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Neurology · 1991 · 5,023 citations
Some Methods for Strengthening the Common χ 2 Tests
Biometrics · 1954 · 3,661 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
